Related Experiment Videos
Immunological evaluation after splenectomy for hairy cell leukemia--a case report
H Yoshioka1, N Shimizu, M Maeta
1First Department of Surgery, University Hospital, Tottori University of School of Medicine, Yonago, Japan.
The Japanese Journal of Surgery
|July 1, 1987
Summary
Splenectomy can improve immune function in patients with hairy cell leukemia (HCL). This study shows improved T cell subsets and lymphocyte response after spleen removal in an HCL patient.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Hairy cell leukemia (HCL) often presents with reduced immunocompetence.
- Splenectomy is frequently recommended as a primary treatment for HCL.
Observation:
- A 46-year-old Japanese male with HCL underwent splenectomy.
- Immunological parameters were assessed pre- and post-operatively.
Findings:
- Pre-splenectomy, the patient exhibited decreased T cell subsets (OKT3, OKT4, OKT8), a reduced OKT4/OKT8 ratio, and impaired lymphocyte blastic response.
- Post-splenectomy, there was a notable increase in OKT4 positive cells relative to OKT8 cells, alongside an improved lymphocyte blastic response.
Implications:
- Splenectomy may lead to significant immunological recovery in HCL patients.
- This suggests a potential benefit of splenectomy in restoring immune competence in HCL.
- Long-term immunological improvement was observed one year post-surgery.